Arcuate neuropeptide y inhibits sympathetic nerve activity via multiple neuropathways

Journal of Clinical Investigation

Volumn 127, Issue 7, 2017, Pages 2868-2880

  Shi, Zhigang ^a   Madden, Christopher J ^b   Brooks, Virginia L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; AGRP PROTEIN, MOUSE; NEUROPEPTIDE Y RECEPTOR; NPY1R PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; HEART RATE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NERVE PROJECTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLANCHNIC NERVE; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; CHRONIC DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

AGOUTI-RELATED PROTEIN; ANIMALS; ARCUATE NUCLEUS OF HYPOTHALAMUS; BLOOD PRESSURE; CHRONIC DISEASE; GENE EXPRESSION REGULATION; HEART RATE; MICE; MICE, TRANSGENIC; NEUROPEPTIDE Y; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RECEPTORS, NEUROPEPTIDE Y; SYMPATHETIC NERVOUS SYSTEM;

EID: 85021758698     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI92008     Document Type: Article

References (81)

1. Davy KP, Orr JS. Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev. 2009;33(2):116-124.
2. Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116(6):976-990.
3. Hall JE, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285(23):17271-17276.
4. Cassaglia PA, et al. Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation. J Physiol (Lond). 2014;592(7):1655-1675.
5. Shi Z, Li B, Brooks VL. Role of the paraventricular nucleus of the hypothalamus in the sympathoexcitatory effects of leptin. Hypertension. 2015;66(5):1034-1041.
6. Beck B. Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond, B, Biol Sci. 2006;361(1471):1159-1185.
7. Cassaglia PA, Shi Z, Brooks VL. Insulin increases sympathetic nerve activity in part by suppression of tonic inhibitory neuropeptide Y inputs into the paraventricular nucleus in female rats. Am J Physiol Regul Integr Comp Physiol. 2016;311(1):R97-R103.
8. Kawabe T, Kawabe K, Sapru HN. Cardiovascular responses to chemical stimulation of the hypothalamic arcuate nucleus in the rat: role of the hypothalamic paraventricular nucleus. PLoS ONE. 2012;7(9):e45180.
9. Grove KL, Smith MS. Ontogeny of the hypothalamic neuropeptide Y system. Physiol Behav. 2003;79(1):47-63.
10. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol. 1985;241(2):138-153.
11. Lee SJ, et al. Efferent projections of neuropeptide Y-expressing neurons of the dorsomedial hypothalamus in chronic hyperphagic models. J Comp Neurol. 2013;521(8):1891-1914.
12. Reichmann F, Holzer P. Neuropeptide Y: a stressful review. Neuropeptides. 2016;55:99-109.
13. Brothers SP, Wahlestedt C. Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol Med. 2010;2(11):429-439.
14. Krashes MJ, et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest. 2011;121(4):1424-1428.
15. Stachniak TJ, Ghosh A, Sternson SM. Chemogenetic synaptic silencing of neural circuits localizes a hypothalamus→midbrain pathway for feeding behavior. Neuron. 2014;82(4):797-808.
16. Broberger C, Johansen J, Johansson C, Schalling M, Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A. 1998;95(25):15043-15048.
17. MacLaren DA, et al. Clozapine N-oxide administration produces behavioral effects in Long-Evans rats: Implications for designing DREADD experiments. eNeuro. 2016;3(5): ENEURO. 0219-16.2016.
18. Jann MW, Lam YW, Chang WH. Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration. Arch Int Pharmacodyn Ther. 1994;328(2):243-250.
19. Bagnol D, et al. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci. 1999;19(18):RC26.
20. Kopp J, et al. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience. 2002;111(3):443-532.
21. Sirensen AT, Kanter-Schlifke I, Lin EJ, During MJ, Kokaia M. Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Mol Cell Neurosci. 2008;39(2):229-237.
22. Fetissov SO, Kopp J, Hökfelt T. Distribution of NPY receptors in the hypothalamus. Neuropeptides. 2004;38(4):175-188.
23. Fetissov SO, Byrne LC, Hassani H, Ernfors P, Hökfelt T. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. J Comp Neurol. 2004;470(3):256-265.
24. Atasoy D, Betley JN, Su HH, Sternson SM. Deconstruction of a neural circuit for hunger. Nature. 2012;488(7410):172-177.
25. Sutton AK, Pei H, Burnett KH, Myers MG, Rhodes CJ, Olson DP. Control of food intake and energy expenditure by Nos1 neurons of the paraventricular hypothalamus. J Neurosci. 2014;34(46):15306-15318.
26. Shi Z, Cassaglia PA, Gotthardt LC, Brooks VL. Hypothalamic paraventricular and arcuate nuclei contribute to elevated sympathetic nerve activity in pregnant rats: roles of neuropeptide Y and α-melanocyte-stimulating hormone. Hypertension. 2015;66(6):1191-1198.
27. Joppa MA, Ling N, Chen C, Gogas KR, Foster AC, Markison S. Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia. Peptides. 2005;26(11):2294-2301.
28. Sutton GM, et al. The melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci. 2008;28(48):12946-12955.
29. Cassaglia PA, Hermes SM, Aicher SA, Brooks VL. Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J Physiol (Lond). 2011;589(Pt 7):1643-1662.
30. Pina MM, Young EA, Ryabinin AE, Cunningham CL. The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice. Neuropharmacology. 2015;99:627-638.
31. Flint RR, Chang T, Lydic R, Baghdoyan HA. GABA(A) receptors in the pontine reticular formation of C57BL/6J mouse modulate neurochemical, electrographic, and behavioral phenotypes of wakefulness. J Neurosci. 2010;30(37):12301-12309.
32. Madden CJ, Morrison SF. Neurons in the paraventricular nucleus of the hypothalamus inhibit sympathetic outflow to brown adipose tissue. Am J Physiol Regul Integr Comp Physiol. 2009;296(3):R831-R843.
33. Cao WH, Fan W, Morrison SF. Medullary pathways mediating specific sympathetic responses to activation of dorsomedial hypothalamus. Neuroscience. 2004;126(1):229-240.
34. Gautron L, Cravo RM, Elmquist JK, Elias CF. Discrete melanocortin-sensitive neuroanatomical pathway linking the ventral premmamillary nucleus to the paraventricular hypothalamus. Neuroscience. 2013;240:70-82.
35. Chambers AP, Woods SC. The role of neuropeptide Y in energy homeostasis. Handb Exp Pharmacol. 2012;(209):23-45.
36. Shi YC, et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab. 2013;17(2):236-248.
37. Wu Q, Palmiter RD. GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism. Eur J Pharmacol. 2011;660(1):21-27.
38. Sapru HN. Role of the hypothalamic arcuate nucleus in cardiovascular regulation. Auton Neurosci. 2013;175(1-2):38-50.
39. Roseberry AG, Liu H, Jackson AC, Cai X, Friedman JM. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron. 2004;41(5):711-722.
40. Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K, van den Pol AN. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci. 2005;25(32):7406-7419.
41. Fu LY, Acuna-Goycolea C, van den Pol AN. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci. 2004;24(40):8741-8751.
42. Li P, Cui BP, Zhang LL, Sun HJ, Liu TY, Zhu GQ. Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure. Exp Physiol. 2013;98(2):435-443.
43. Krashes MJ, Shah BP, Koda S, Lowell BB. Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab. 2013;18(4):588-595.
44. Ter Horst GJ, Luiten PG. Phaseolus vulgaris leuco-agglutinin tracing of intrahypothalamic connections of the lateral, ventromedial, dorsomedial and paraventricular hypothalamic nuclei in the rat. Brain Res Bull. 1987;18(2):191-203.
45. Thompson RH, Canteras NS, Swanson LW. Organization of projections from the dorsomedial nucleus of the hypothalamus: a PHA-L study in the rat. J Comp Neurol. 1996;376(1):143-173.
46. Dai J, Van Der Vliet J, Swaab DF, Buijs RM. Postmortem anterograde tracing of intrahypothalamic projections of the human dorsomedial nucleus of the hypothalamus. J Comp Neurol. 1998;401(1):16-33.
47. Zhang Y, et al. Leptin-receptor-expressing neurons in the dorsomedial hypothalamus and median preoptic area regulate sympathetic brown adipose tissue circuits. J Neurosci. 2011;31(5):1873-1884.
48. Fontes MA, Xavier CH, de Menezes RC, Dimicco JA. The dorsomedial hypothalamus and the central pathways involved in the cardiovascular response to emotional stress. Neuroscience. 2011;184:64-74.
49. Stornetta RL, Akey PJ, Guyenet PG. Location and electrophysiological characterization of rostral medullary adrenergic neurons that contain neuropeptide Y mRNA in rat medulla. J Comp Neurol. 1999;415(4):482-500.
50. Abbott SB, DePuy SD, Nguyen T, Coates MB, Stornetta RL, Guyenet PG. Selective optogenetic activation of rostral ventrolateral medullary catecholaminergic neurons produces cardiorespiratory stimulation in conscious mice. J Neurosci. 2013;33(7):3164-3177.
51. Broberger C, Visser TJ, Kuhar MJ, Hökfelt T. Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology. 1999;70(5):295-305.
52. DiMicco JA, Samuels BC, Zaretskaia MV, Zaretsky DV. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacol Biochem Behav. 2002;71(3):469-480.
53. Dampney RA. Central mechanisms regulating coordinated cardiovascular and respiratory function during stress and arousal. Am J Physiol Regul Integr Comp Physiol. 2015;309(5):R429-R443.
54. Fontes MA, Tagawa T, Polson JW, Cavanagh SJ, Dampney RA. Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus. Am J Physiol Heart Circ Physiol. 2001;280(6):H2891-H2901.
55. Horiuchi J, McAllen RM, Allen AM, Killinger S, Fontes MA, Dampney RA. Descending vasomotor pathways from the dorsomedial hypothalamic nucleus: role of medullary raphe and RVLM. Am J Physiol Regul Integr Comp Physiol. 2004;287(4):R824-R832.
56. Papp RS, Palkovits M. Brainstem projections of neurons located in various subdivisions of the dorsolateral hypothalamic area-an anterograde tract-tracing study. Front Neuroanat. 2014;8:34.
57. Yoshihara T, Honma S, Honma K. Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus. Am J Physiol. 1996;270(4 Pt 1):E589-E595.
58. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A. 1991;88(23):10931-10935.
59. Johnstone LE, Fong TM, Leng G. Neuronal activation in the hypothalamus and brainstem during feeding in rats. Cell Metab. 2006;4(4):313-321.
60. Mandelblat-Cerf Y, et al. Arcuate hypothalamic AgRP and putative POMC neurons show opposite changes in spiking across multiple timescales. Elife. 2015;4:e07122.
61. Nogueiras R, Williams LM, Dieguez C. Ghrelin: new molecular pathways modulating appetite and adiposity. Obes Facts. 2010;3(5):285-292.
62. Nakamura Y, Yanagawa Y, Morrison SF, Nakamura K. Medullary reticular neurons mediate neuropeptide Y-induced metabolic inhibition and mastication. Cell Metab. 2017;25(2):322-334.
63. Bruinstroop E, Fliers E, Kalsbeek A. Hypothalamic control of hepatic lipid metabolism via the autonomic nervous system. Best Pract Res Clin Endocrinol Metab. 2014;28(5):673-684.
64. Joly-Amado A, et al. The hypothalamic arcuate nucleus and the control of peripheral substrates. Best Pract Res Clin Endocrinol Metab. 2014;28(5):725-737.
65. Nogueiras R, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest. 2007;117(11):3475-3488.
66. Bartness TJ, Liu Y, Shrestha YB, Ryu V. Neural innervation of white adipose tissue and the control of lipolysis. Front Neuroendocrinol. 2014;35(4):473-493.
67. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Ther. 2010;126(2):159-172.
68. Kohsaka A, et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007;6(5):414-421.
69. Hansen MJ, Jovanovska V, Morris MJ. Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem. 2004;88(4):909-916.
70. Lin S, Storlien LH, Huang XF. Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res. 2000;875(1-2):89-95.
71. la Fleur SE, van Rozen AJ, Luijendijk MC, Groeneweg F, Adan RA. A free-choice high-fat high-sugar diet induces changes in arcuate neuropeptide expression that support hyperphagia. Int J Obes (Lond). 2010;34(3):537-546.
72. Lee AK, et al. Effect of high-fat feeding on expression of genes controlling availability of dopamine in mouse hypothalamus. Nutrition. 2010;26(4):411-422.
73. Zammaretti F, Panzica G, Eva C. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in moderate/high fat, high-energy diet-fed mice. J Physiol (Lond). 2007;583(Pt 2):445-454.
74. Mele P, Zammaretti F, Longo A, Panzica G, Oberto A, Eva C. Sex-dependent regulation of hypothalamic neuropeptide Y-Y1 receptor gene expression in leptin treated obese (ob/ob) or lean mice. Brain Res. 2016;1649(Pt A):102-109.
75. Tong Q, Ye CP, Jones JE, Elmquist JK, Lowell BB. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat Neurosci. 2008;11(9):998-1000.
76. van den Pol AN, et al. Neuromedin B and gastrinreleasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons. J Neurosci. 2009;29(14):4622-4639.
77. Opland D, et al. Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity. Mol Metab. 2013;2(4):423-434.
78. Garfield AS, et al. A neural basis for melanocortin-4 receptor-regulated appetite. Nat Neurosci. 2015;18(6):863-871.
79. Harlan SM, Morgan DA, Dellsperger DJ, Myers MG, Mark AL, Rahmouni K. Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor. Hypertension. 2011;57(3):627-632.
80. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. New York, New York, USA: Academic Press; 2001.
81. Madden CJ, Tupone D, Cano G, Morrison SF. α2 Adrenergic receptor-mediated inhibition of thermogenesis. J Neurosci. 2013;33(5):2017-2028.